Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Transcriptome-wide association study reveals candidate causal genes for lung cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cervical cancer risk in women living with HIV across four continents: A multicohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Transcriptome-wide association study reveals candidate causal genes for lung cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Incidental lymphopenia and mortality: a prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • O Obazee
  • L Archibugi
  • A Andriulli
  • P Soucek
  • E Małecka-Panas
  • A Ivanauskas
  • T Johnson
  • M Gazouli
  • T Pausch
  • R T Lawlor
  • G M Cavestro
  • A C Milanetto
  • M Di Leo
  • C Pasquali
  • P Hegyi
  • A Szentesi
  • C E Radu
  • C Gheorghe
  • G E Theodoropoulos
  • F Bergmann
  • H Brenner
  • L Vodickova
  • V Katzke
  • D Campa
  • O Strobel
  • J Kaiser
  • R Pezzilli
  • F Federici
  • B Mohelnikova-Duchonova
  • U Boggi
  • R Lemstrova
  • J S Johansen
  • S E Bojesen
  • I Chen
  • B V Jensen
  • G Capurso
  • V Pazienza
  • C Dervenis
  • C Sperti
  • A Mambrini
  • T Hackert
  • R Kaaks
  • D Basso
  • R Talar-Wojnarowska
  • E Maiello
  • J R Izbicki
  • K Cuk
  • K U Saum
  • M Cantore
  • J Kupcinskas
  • O Palmieri
  • G Delle Fave
  • S Landi
  • R Salvia
  • P Fogar
  • Y K Vashist
  • A Scarpa
  • P Vodicka
  • C Tjaden
  • E Iskierka-Jazdzewska
  • F Canzian
Vis graf over relationer

Rare truncating BRCA2 K3326X (rs11571833) and pathogenic CHEK2 I157T (rs17879961) variants have previously been implicated in familial pancreatic ductal adenocarcinoma (PDAC), but not in sporadic cases. The effect of both mutations in important DNA repair genes on sporadic PDAC risk may shed light on the genetic architecture of this disease. Both mutations were genotyped in germline DNA from 2,935 sporadic PDAC cases and 5,626 control subjects within the PANcreatic Disease ReseArch (PANDoRA) consortium. Risk estimates were evaluated using multivariate unconditional logistic regression with adjustment for possible confounders such as sex, age and country of origin. Statistical analyses were two-sided with p values <0.05 considered significant. K3326X and I157T were associated with increased risk of developing sporadic PDAC (odds ratio (OR dom) = 1.78, 95% confidence interval (CI) = 1.26–2.52, p = 1.19 × 10 −3 and OR dom = 1.74, 95% CI = 1.15–2.63, p = 8.57 × 10 −3, respectively). Neither mutation was significantly associated with risk of developing early-onset PDAC. This retrospective study demonstrates novel risk estimates of K3326X and I157T in sporadic PDAC which suggest that upon validation and in combination with other established genetic and non-genetic risk factors, these mutations may be used to improve pancreatic cancer risk assessment in European populations. Identification of carriers of these risk alleles as high-risk groups may also facilitate screening or prevention strategies for such individuals, regardless of family history.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cancer
Vol/bind145
Udgave nummer3
Sider (fra-til)686-693
Antal sider8
ISSN0020-7136
DOI
StatusUdgivet - 1 aug. 2019

ID: 56638170